Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gen-Bio is a nutraceutical dietary supplement developed by Genspec Lifesciences, formulated as an oral hard gelatin capsule. It contains a combination of nanocurcumin (300mg) and lycopene (5000 IU). Nanocurcumin is a nanoparticle-based formulation of curcumin designed to overcome the compound's naturally poor bioavailability, allowing it to more effectively inhibit pro-inflammatory pathways such as NF-kB. Lycopene is a potent carotenoid antioxidant that protects cells from oxidative damage by scavenging reactive oxygen species. Gen-Bio is marketed in India for a wide range of health support indications, including boosting immunity, promoting cardiovascular and joint health, and managing inflammation-related conditions such as joint pain and systemic oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gen-Bio.